BCR and prostate adenocarcinoma: Although the results of the univariate model including the stage of PRAD were equivocal, there was a consistent trend towards a worse BCR-free survival rate among localized stratum-negative vs. stratum-positive PRAD cases and locally advanced disease, respectively (global log-rank p < 0.0001).